Media coverage
22
Media coverage
Title How Merck's dividend compares to AbbVie Media name/outlet Global Round Up - Sectors Country/Territory United Kingdom Date 1/23/25 Persons Mary Davis Title Merck's Earnings Growth Lags Novartis India Media name/outlet Global Round Up - Sectors Country/Territory United Kingdom Date 1/23/25 Persons Mary Davis Title Merck- 6 Reasons Investors Remain Bearish (and 5 Reasons Why Bullish) Media name/outlet Global Round Up - Sectors Country/Territory United Kingdom Date 1/23/25 Persons Mary Davis Title Merck continues to underperform Roche by 8.9% year to date Media name/outlet Global Round Up - Sectors Country/Territory United Kingdom Date 1/23/25 Persons Mary Davis Title Merck's Earnings Growth Lags AstraZeneca Pharma India Media name/outlet Global Round Up - Sectors Country/Territory United Kingdom Date 1/23/25 Persons Mary Davis Title Merck's Earnings Growth Lags Peers Media name/outlet Global Round Up - Sectors Country/Territory United Kingdom Date 1/23/25 Persons Mary Davis Title How Merck's Tax Rate compares to Its Peers Media name/outlet Global Round Up - Sectors Country/Territory United Kingdom Date 1/23/25 Persons Mary Davis Title Merck continues to outperform Novartis India by 3.7% year to date Media name/outlet Global Round Up - Sectors Country/Territory United Kingdom Date 1/23/25 Persons Mary Davis Title Merck's Earnings Growth Lags Pfizer Media name/outlet Global Round Up - Sectors Country/Territory United Kingdom Date 1/23/25 Persons Mary Davis Title Merck continues to underperform Bristol Myers Squibb by 5.2% year to date Media name/outlet Global Round Up - Sectors Country/Territory United Kingdom Date 1/23/25 Persons Mary Davis Title Merck continues to underperform AstraZeneca by 18.1% year to date Media name/outlet Global Round Up - Sectors Country/Territory United Kingdom Date 1/23/25 Persons Mary Davis Title How Merck's dividend compares to Eli Lilly and Company Media name/outlet Global Round Up - Sectors Country/Territory United Kingdom Date 1/23/25 Persons Mary Davis Title Merck's Earnings Growth Lags Roche Media name/outlet Global Round Up - Sectors Country/Territory United Kingdom Date 1/23/25 Persons Mary Davis Title Merck's Earnings Growth Lags AstraZeneca Media name/outlet Global Round Up - Sectors Country/Territory United Kingdom Date 1/23/25 Persons Mary Davis Title How Merck's dividend compares to Johnson and Johnson Media name/outlet Global Round Up - Sectors Country/Territory United Kingdom Date 1/23/25 Persons Mary Davis Title Merck continues to underperform Pfizer by 1.9% year to date Media name/outlet Global Round Up - Sectors Country/Territory United Kingdom Date 1/23/25 Persons Mary Davis Title Merck's Earnings Growth Lags AbbVie Media name/outlet Global Round Up - Sectors Country/Territory United Kingdom Date 1/23/25 Persons Mary Davis Title Merck continues to outperform AbbVie by 1.0% year to date Media name/outlet Global Round Up - Sectors Country/Territory United Kingdom Date 1/23/25 Persons Mary Davis Title Merck's Earnings Growth Lags Eli Lilly and Company Media name/outlet Global Round Up - Sectors Country/Territory United Kingdom Date 1/23/25 Persons Mary Davis Title Merck continues to underperform Eli Lilly and Company by 1.5% year to date Media name/outlet Global Round Up - Sectors Country/Territory United Kingdom Date 1/23/25 Persons Mary Davis Title Merck continues to underperform Johnson and Johnson by 4.3% year to date Media name/outlet Global Round Up - Sectors Country/Territory United Kingdom Date 1/23/25 Persons Mary Davis Title Merck's Earnings Growth Lags Johnson and Johnson Media name/outlet Global Round Up - Sectors Country/Territory United Kingdom Date 1/23/25 Persons Mary Davis